Zai Lab Stock Forecast
NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 2:43 PM ET
ZLAB analyst consensus
Consensus (12 analysts)
strong_buy
Avg. price target
$33.14+34.01%
- Strong buy 2
- Buy 9
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Zai Lab (2026-10-07), 11 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $33.14, with a high estimate of $50.00 and a low estimate of $24.25. The average target implies upside of 34.0% from the current price of $24.73.
The spread between the highest and lowest targets is 106.2%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ZLAB.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 17% |
| Buy | 9 | 75% |
| Hold | 1 | 8% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $24.25 | -1.94% |
| Average target | $33.14 | +34.01% |
| High target | $50.00 | +102.18% |